Becker's Healthcare June 28, 2024
The House Ways and Means Committee advanced a proposal to allow Medicare coverage of weight loss drugs for beneficiaries who were prescribed the drug for at least a year before switching to Medicare.
At a markup session June 27, the committee advanced the Treat and Reduce Obesity Act of 2023, which would provide Medicare coverage of the drugs in limited circumstances.
Under current law, Medicare cannot pay for any drug prescribed solely for weight loss. A version of theTreat and Reduce Obesity Act introduced in 2023 would have lifted the ban on Medicare payment for weight loss drugs, including Wegovy and Zepbound, but the bill did not gain traction in Congress.
The Ways and Means Committee since...
Today's Sponsors
Today's Sponsor